Literature DB >> 22765366

Current understanding of the pathophysiologic mechanisms of canine atopic dermatitis.

Rosanna Marsella1, Candace A Sousa, Andrea J Gonzales, Valerie A Fadok.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22765366     DOI： 10.2460/javma.241.2.194

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN： 0003-1488            Impact factor:   1.936


× No keyword cloud information.
  8 in total

1.  Case study on Canine Atopic Dermatitis from a medico-legal viewpoint: A takeaway of knowledge for practicing veterinary clinicians.

Authors:  Michela Pugliese; Rocky La Maestra; Annalisa Previti; Annastella Falcone; Annamaria Passantino
Journal:  Open Vet J       Date:  2022-03-01

2.  Prevalence of and risk factors for increased serum levels of allergen-specific IgE in a population of Norwegian dogs.

Authors:  Annelin A Bjelland; Frederik L Dolva; Ane Nødtvedt; Bente K Sævik
Journal:  Acta Vet Scand       Date:  2014-12-05       Impact factor: 1.695

3.  Seven common mistakes to avoid in achieving long-term success with dermatology patients.

Authors:  Lowell Ackerman
Journal:  Vet Med Sci       Date:  2015-03-04

4.  Detection of Serum Allergen-Specific IgE in Atopic Dogs Tested in Northern Italy: Preliminary Study.

Authors:  Morena Di Tommaso; Alessia Luciani; Paolo Emidio Crisi; Marica Beschi; Paolo Rosi; Francesca Rocconi; Arianna Miglio
Journal:  Animals (Basel)       Date:  2021-02-01       Impact factor: 2.752

5.  A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.

Authors:  Peter R Little; Vickie L King; Kylie R Davis; Sallie B Cosgrove; Michael R Stegemann
Journal:  Vet Dermatol       Date:  2014-12-12       Impact factor: 1.589

Review 6.  Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification.

Authors:  Patrick Hensel; Domenico Santoro; Claude Favrot; Peter Hill; Craig Griffin
Journal:  BMC Vet Res       Date:  2015-08-11       Impact factor: 2.741

7.  A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.

Authors:  Sallie B Cosgrove; Jody A Wren; Dawn M Cleaver; Kelly F Walsh; Stacey I Follis; Vickie I King; Jezaniah-Kira S Tena; Michael R Stegemann
Journal:  Vet Dermatol       Date:  2013-12       Impact factor: 1.589

8.  Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.

Authors:  Caroline Gadeyne; Peter Little; Vickie L King; Nigel Edwards; Kylie Davis; Michael R Stegemann
Journal:  Vet Dermatol       Date:  2014-08-11       Impact factor: 1.589
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.